Autologous Gene-modified PD-1-positive T-lymphocytes ScTIL210

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A preparation of autologous programmed cell death protein 1 (PD-1; PDCD1; CD279)-positive T-lymphocytes transduced with a lentiviral vector encoding for an as of yet undisclosed receptor, with potential immunomodulating activity. Upon administration, autologous gene-modified PD-1-positive T-lymphocytes ScTIL210 may recognize and kill the patient's tumor cells through as of yet not elucidated receptor binding.

**Synonyms:** - Autologous Gene-modified PD-1-positive T-cells ScTIL210 - ScTIL 210 - ScTIL-210 - ScTIL210